Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:PI O-34:0)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003144 AN005160 On-target, dual aminopeptidase inhibition provides cross-species antimalarial activity Blood Plasmodium falciparum Malaria Monash University LC-MS
ST002792 AN004543 Chemoproteomics validates selective targeting of Plasmodium M1 alanyl aminopeptidase as a cross-species strategy to treat malaria Blood Plasmodium falciparum Malaria Monash University LC-MS
ST002522 AN004156 Lipidomics study on the effect of LBP protein on hepatic lipid composition in mice Liver Mouse Oxidative stress University of Science and Technology of China LC-MS
ST002108 AN003449 Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 3) Blood Plasmodium falciparum Malaria Monash University LC-MS
ST002057 AN003349 Distinct Human Hepatocyte Lipidomics Profiles for Nonalcoholic Steatohepatitis and In Vitro-Induced Steatosis Cultured cells Human NASH Monash Institute of Pharmaceutical Sciences LC-MS
  logo